ZMYND8 and breast carcinoma: In ZR-75-30 breast cancer cells, ZMYND8 promotes the recruitment of KDM5C to the super-enhancer region, shown by the co-binding of ZMYND8 and KDM5C to 88.7% super-enhancers (Figure 3B) [25].